Science of Stability 2015

Groton, Connecticut

August 25, 2015

FOXWOODS RESORT HOSTS the Inaugural Science of Stability Conference (SOS-2015)

Determining if a product will remain safe and effective at the end of its shelf-life is an obligation of both Industry and Regulators. Unfortunately, many Regulations are not appropriate for meeting this goal, or are vague in their directions. Where science keeps up with advances as they happen; regulations tend to remain in place for decades even when they are no longer of value (or are even counterproductive).

To address this issue the inaugural Science of Stability Conference (SOS-2015) will take place at Foxwoods Resort October 12th – October 14th, 2015 where scientists and pharma professionals from around the globe will learn about the very latest findings from Industry and Academia. “While most Stability Conferences focus on regulations and requirements; here at SOS-2015: It’s all about the Science.” Said FreeThink Technologies Inc. Chairman and Chief Scientific Officer Dr. Ken Waterman.

In 1987, Dr. Waterman began a 12-year career at Polaroid (Massachusetts) where he invented and brought to market a number of both photographic and non-silver based imaging products.

In 1999, he joined the Pharmaceutical Sciences Division at Pfizer (Connecticut), rising to the rank of Research Fellow. His focus at Pfizer included drug stability, drug delivery technology, biopharmaceutics and prodrug development.  His work on accelerated stability and oxygen absorbers was dramatically successful and has influenced the entire industry.

“Establishing and improving the shelf-life of pharmaceuticals, nutraceuticals and other consumer goods is critical for taking product development to the next level. Despite this, fundamental aspects of Stability Science still remain mysterious to many.”

Stability Conferences are generally focused on making sure the regulations are met; rules, which may be out of date or fail to address whether the regulations make sense in today’s climate. But despite this, the rules do not tell you the most efficient and cost-effective way to develop a product and understanding the Science of Stability gives pharma professionals the ability to know what to do when a product will not meet its stability requirements.

The three day SOS-2015 Conference Program will bring together scientists from the leading global pharma companies such as Eli Lilly, Janssen, Pfizer, Astra Zenika and Merck, together with academic and other thought-leaders in the field including Christian Schöneich, of the University of Kansas, Rod Ketner of Bend Research and industry consultant Steve Baertschi. Highlights include;

  • Examining the latest theories on the role of moisture and temperature on chemical reactions in solids.
  • The use of in silico-modeling for degradation mechanisms.
  • Recent findings in oxidation chemistry related to peroxides.
  • Amorphous dispersion stability.
  • Use of accelerated stability for formulation development.

NOTES FOR EDITORS

SOS-2015 is a conference sponsored by FreeThink Technologies, Inc.; a private R&D company founded in 2011 by Dr. Kenneth Waterman.  FreeThink develops innovative technologies focused on accelerated shelf-life and stability determinations for pharmaceuticals, consumer products, nutraceuticals and medical devices.  Its cutting-edge software package, ASAPprime® , allows customers to rapidly, accurately and confidently determine drug substance and drug product shelf-life.  In addition, FreeThink maintains laboratories in Groton, CT where it conducts laboratory studies for international client companies and develops new pharmaceutical-oriented technologies

For more information contact:

Elise Napper

Operations Manager, FreeThink Technologies Inc.

Call: 860-237-5800 or email: elise.napper@freethinktech.com